ZebraMed.bio

Our Breakthrough Approach

Transforming drug discovery with cutting-edge technology and zebrafish models.

🔥 The Problem

90% of drug candidates fail, costing $125B+ annually. Slow, expensive, and unreliable preclinical screening delays life-saving treatments.

🚀 Our Solution

We automate in vivo drug screening using AI-powered robotics and zebrafish larvae—85% genetically similar to humans—for faster, scalable, and cost-effective testing.

🌍 The Impact

Cut failure risks by 70%, reduce costs by 50%, and accelerate drug discovery timelines by months.

About ZebraMed

Our Story

ZebraMed is transforming drug discovery by combining AI, robotics, and zebrafish models to improve efficiency and accuracy. Our approach reduces costs, accelerates timelines, and minimizes early-stage failures, making preclinical screening more reliable and scalable.

Our Journey

Key milestones in ZebraMed's evolution.

Founding Vision

ZebraMed was founded with the mission to revolutionize preclinical drug discovery using zebrafish models and advanced robotics.
Platform Development

Development of the first fully automated high-throughput screening platform leveraging zebrafish larvae.
Market Access

Offering our services to leading institutions like ZeClinic and hospitals to advance precision medicine.
AI Integration

Integration of AI-driven data analysis to enhance drug discovery and predictive modeling.
Join Us in Shaping the Future of Drug Discovery!